Journalartikel

Potential interactions of rheumatologic medications in the elderly


AutorenlisteLange, U.; Mueller-Ladner, U.

Jahr der Veröffentlichung2012

Seiten539-545

ZeitschriftDer Orthopäde

Bandnummer41

Heftnummer7

ISSN0085-4530

eISSN1433-0431

DOI Linkhttps://doi.org/10.1007/s00132-012-1930-y

VerlagSpringer


Abstract
Improving the safety of prescriptions for elderly patients is of substantial interest for physicians of all specialities as well as for general health policy and health services. Owing to the increase in drug prescriptions with age and various drug-drug interactions, the number of adverse drug event-related hospital admissions needs to be minimized as far as possible. Therefore, the present overview focuses on the most important potential drug-drug interactions with a specific focus on antirheumatic medications prescribed for elderly patients.



Zitierstile

Harvard-ZitierstilLange, U. and Mueller-Ladner, U. (2012) Potential interactions of rheumatologic medications in the elderly, Orthopäde, 41(7), pp. 539-545. https://doi.org/10.1007/s00132-012-1930-y

APA-ZitierstilLange, U., & Mueller-Ladner, U. (2012). Potential interactions of rheumatologic medications in the elderly. Orthopäde. 41(7), 539-545. https://doi.org/10.1007/s00132-012-1930-y



Schlagwörter


adverse drug reactionsCo-medicationCOMORBIDITYDrug interactionsElderlyEVENTSINAPPROPRIATE MEDICATIONSMODIFYING ANTIRHEUMATIC DRUGSNon steroidal anti-inflammatory drugs (NSAIDs)TOCILIZUMAB


Nachhaltigkeitsbezüge


Zuletzt aktualisiert 2025-02-04 um 02:39